Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
T-cell infusion + influenza vaccine is a combination immunotherapy approach that involves the adoptive transfer of T cells along with influenza vaccination. This strategy aims to enhance immune reconstitution and response to vaccines in patients undergoing treatments that compromise their immune system, such as autologous stem cell transplantation or CAR-T cell therapy. The T-cell infusion component typically involves collecting, potentially expanding, and reinfusing the patient's own T cells, while the influenza vaccine component consists of an inactivated influenza vaccine administered before and/or after the cell therapy procedure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on T-cell infusion + influenza vaccine.